Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)-Reference-Cited by-同舟云学术

Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)

Published:2015-10-22 Issue:10 Volume:10 Page:e0140943
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Anagnostopoulos Alexia,Ledergerber Bruno,Jaccard René,Shaw Susy Ann,Stoeckle Marcel,Bernasconi Enos,Barth Jürgen,Calmy Alexandra,Berney Alexandre,Jenewein Josef,Weber Rainer,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation;MA Dew;Psychological medicine,1997

2. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States;EG Bing;Archives of general psychiatry,2001

3. Meta-analysis of the relationship between HIV infection and risk for depressive disorders;JA Ciesla;Am J Psychiat,2001

4. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study;KB Wells;JAMA,1989

5. Depression and cardiovascular comorbidity;AH Glassman;Dialogues Clin Neurosci,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global prevalence of depressive symptoms among people living with HIV/AIDS: a systematic review and meta-analysis of the past five years;AIDS Care;2023-11-23

2. Prevalence of mental distress and factors associated with symptoms of major depression among people living with HIV in Norway;AIDS Care;2023-11

3. Chemsex, HIV, and Psychiatric Diagnosis in Gay or Bisexual Men in Hong Kong;Substance Use & Misuse;2023-04-07

4. Global overview of suicidal behavior and associated risk factors among people living with human immunodeficiency virus: A scoping review;PLOS ONE;2023-03-20

5. One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV;HIV Medicine;2023-03-08